Ameridose LLC, the Westborough pharmacy that agreed to suspend certain operations Wednesday because of its ties to the Framingham company at the center of the deadly outbreak of fungal meningitis, has faced questions about its own safety procedures before.

In 2008, a US Food and Drug Administration inspection found that Ameridose had significant problems with production records, procedures, and drug testing, according to Validation Times, an industry newsletter.